Factors predicting efficacy of allergen injection immunotherapy for grass pollen hayfever: a pilot study. (Up-dosing study)

Trial Profile

Factors predicting efficacy of allergen injection immunotherapy for grass pollen hayfever: a pilot study. (Up-dosing study)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Grass pollen hypersensitivity; Rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 May 2008 Primary endpoint 'Symptom score' has been met.
    • 01 May 2008 Secondary endpoint 'Skin reactivity' has been met.
    • 01 Mar 2008 Secondary endpoint 'Immunoglobulin G levels' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top